These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndrome. Lai ZW; Marchena-Mendez I; Perl A Clin Immunol; 2015 Jun; 158(2):148-52. PubMed ID: 25862984 [TBL] [Abstract][Full Text] [Related]
45. Mutations in TBCK, Encoding TBC1-Domain-Containing Kinase, Lead to a Recognizable Syndrome of Intellectual Disability and Hypotonia. Bhoj EJ; Li D; Harr M; Edvardson S; Elpeleg O; Chisholm E; Juusola J; Douglas G; Guillen Sacoto MJ; Siquier-Pernet K; Saadi A; Bole-Feysot C; Nitschke P; Narravula A; Walke M; Horner MB; Day-Salvatore DL; Jayakar P; Vergano SA; Tarnopolsky MA; Hegde M; Colleaux L; Crino P; Hakonarson H Am J Hum Genet; 2016 Apr; 98(4):782-8. PubMed ID: 27040691 [TBL] [Abstract][Full Text] [Related]
46. De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental Delay. Vissers LELM; Kalvakuri S; de Boer E; Geuer S; Oud M; van Outersterp I; Kwint M; Witmond M; Kersten S; Polla DL; Weijers D; Begtrup A; McWalter K; Ruiz A; Gabau E; Morton JEV; Griffith C; Weiss K; Gamble C; Bartley J; Vernon HJ; Brunet K; Ruivenkamp C; Kant SG; Kruszka P; Larson A; Afenjar A; Billette de Villemeur T; Nugent K; ; Raymond FL; Venselaar H; Demurger F; Soler-Alfonso C; Li D; Bhoj E; Hayes I; Hamilton NP; Ahmad A; Fisher R; van den Born M; Willems M; Sorlin A; Delanne J; Moutton S; Christophe P; Mau-Them FT; Vitobello A; Goel H; Massingham L; Phornphutkul C; Schwab J; Keren B; Charles P; Vreeburg M; De Simone L; Hoganson G; Iascone M; Milani D; Evenepoel L; Revencu N; Ward DI; Burns K; Krantz I; Raible SE; Murrell JR; Wood K; Cho MT; van Bokhoven H; Muenke M; Kleefstra T; Bodmer R; de Brouwer APM Am J Hum Genet; 2020 Jul; 107(1):164-172. PubMed ID: 32553196 [TBL] [Abstract][Full Text] [Related]
47. Clinical and molecular characterization of de novo loss of function variants in HNRNPU. Leduc MS; Chao HT; Qu C; Walkiewicz M; Xiao R; Magoulas P; Pan S; Beuten J; He W; Bernstein JA; Schaaf CP; Scaglia F; Eng CM; Yang Y Am J Med Genet A; 2017 Oct; 173(10):2680-2689. PubMed ID: 28815871 [TBL] [Abstract][Full Text] [Related]
48. Neurodevelopmental phenotype caused by a de novo PTPN4 single nucleotide variant disrupting protein localization in neuronal dendritic spines. Szczałuba K; Chmielewska JJ; Sokolowska O; Rydzanicz M; Szymańska K; Feleszko W; Włodarski P; Biernacka A; Murcia Pienkowski V; Walczak A; Bargeł E; Królewczyk K; Nowacka A; Stawiński P; Nowis D; Dziembowska M; Płoski R Clin Genet; 2018 Dec; 94(6):581-585. PubMed ID: 30238967 [TBL] [Abstract][Full Text] [Related]
49. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly. Negishi Y; Miya F; Hattori A; Johmura Y; Nakagawa M; Ando N; Hori I; Togawa T; Aoyama K; Ohashi K; Fukumura S; Mizuno S; Umemura A; Kishimoto Y; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Nakanishi M; Saitoh S BMC Med Genet; 2017 Jan; 18(1):4. PubMed ID: 28086757 [TBL] [Abstract][Full Text] [Related]
50. What is known about pediatric antiphospholipid syndrome? Meroni PL; Argolini LM; Pontikaki I Expert Rev Hematol; 2016 Oct; 9(10):977-85. PubMed ID: 27615277 [TBL] [Abstract][Full Text] [Related]
51. The clinical presentation caused by truncating CHD8 variants. Douzgou S; Liang HW; Metcalfe K; Somarathi S; Tischkowitz M; Mohamed W; Kini U; McKee S; Yates L; Bertoli M; Lynch SA; Holder S; ; Banka S Clin Genet; 2019 Jul; 96(1):72-84. PubMed ID: 31001818 [TBL] [Abstract][Full Text] [Related]
52. Expanding the genetic and phenotypic spectrum of Baker-Gordon syndrome: a new Cotrina-Vinagre FJ; Rodríguez-García ME; Pozo-Filíu LD; Quijada-Fraile P; Martínez-Azorín F J Genet; 2024; 103():. PubMed ID: 39049490 [TBL] [Abstract][Full Text] [Related]
53. De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders. Nabais Sá MJ; El Tekle G; de Brouwer APM; Sawyer SL; Del Gaudio D; Parker MJ; Kanani F; van den Boogaard MH; van Gassen K; Van Allen MI; Wierenga K; Purcarin G; Elias ER; Begtrup A; Keller-Ramey J; Bernasocchi T; van de Wiel L; Gilissen C; Venselaar H; Pfundt R; Vissers LELM; Theurillat JP; de Vries BBA Am J Hum Genet; 2020 Mar; 106(3):405-411. PubMed ID: 32109420 [TBL] [Abstract][Full Text] [Related]
54. The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome. Tucci A; Ronzoni L; Arduino C; Salmin P; Esposito S; Milani D BMC Med Genet; 2016 Mar; 17():22. PubMed ID: 26969503 [TBL] [Abstract][Full Text] [Related]
55. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227 [TBL] [Abstract][Full Text] [Related]
56. De novo mutations in HNRNPU result in a neurodevelopmental syndrome. Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577 [TBL] [Abstract][Full Text] [Related]
58. Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes. de Kovel CGF; Syrbe S; Brilstra EH; Verbeek N; Kerr B; Dubbs H; Bayat A; Desai S; Naidu S; Srivastava S; Cagaylan H; Yis U; Saunders C; Rook M; Plugge S; Muhle H; Afawi Z; Klein KM; Jayaraman V; Rajagopalan R; Goldberg E; Marsh E; Kessler S; Bergqvist C; Conlin LK; Krok BL; Thiffault I; Pendziwiat M; Helbig I; Polster T; Borggraefe I; Lemke JR; van den Boogaardt MJ; Møller RS; Koeleman BPC JAMA Neurol; 2017 Oct; 74(10):1228-1236. PubMed ID: 28806457 [TBL] [Abstract][Full Text] [Related]
59. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia. Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779 [TBL] [Abstract][Full Text] [Related]
60. Confirmation and further delineation of the SMG9-deficiency syndrome, a rare and severe developmental disorder. Lecoquierre F; Bonnevalle A; Chadie A; Gayet C; Dumant-Forest C; Renaux-Petel M; Leca JB; Hazelzet T; Brasseur-Daudruy M; Louillet F; Muraine M; Coutant S; Quenez O; Boland A; Deleuze JF; Frebourg T; Goldenberg A; Saugier-Veber P; Guerrot AM; Nicolas G Am J Med Genet A; 2019 Nov; 179(11):2257-2262. PubMed ID: 31390136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]